BSL-3 Preclinical Services
The INFRAFRONTIER BSL-3 Preclinical Services offer scientists access to cutting-edge BioSafety Level 3 pipelines to test therapeutics against infectious diseases. These services support translational research by enabling in vivo studies under high-containment conditions.
If interested, please
Request Our Service Here
INFRAFRONTIER BSL-3 Preclinical Services
INFRAFRONTIER offers access to advanced Preclinical BioSafety Level 3 (BSL-3) services for in vivo testing of infectious diseases therapeutics. These services provide researchers with the opportunity to conduct infectious studies using rodent models under high-containment conditions, enabling safe and effective investigation of high-risk pathogens, including emerging viruses and multidrug-resistant bacteria.
By bridging the gap between discovery and clinical development, INFRAFRONTIER’s BSL-3 Services help accelerate translational research. Our service and the expertise of our partners can support pandemic preparedness, antimicrobial resistance, or novel vaccine strategies.
Access to these services is provided on a fee-for-service or direct collaboration with our BSL-3 partners. Researchers benefit from a user-friendly application process, expert user support, high scientific standards, and a collaborative approach designed to maximise research impact.
INFRAFRONTIER Partners Offering BSL-3 Preclinical Services:
Click on the pins to learn more about the providers!
Which partners provide BSL-3 Preclinical Services?
Additional Resources and Services
The International Mouse Phenotyping Consortium (IMPC)
The largest and foremost scientific consortium for mouse model generation and phenotyping
INFRAFRONTIER Axenic Service
Germ-free derivation of mouse strains for gnotobiotic studies